Clinical trial
Non-interventional Register-based Study to Analyze Patient Characteristics, Treatment Patterns and Healthcare Resource Utilization in Adult Patients With Metastatic Melanoma
NCT06369428 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-interventional Register-based Study to Analyze Patient Characteristics, Treatment Patterns and Healthcare Resource Utilization in Adult Patients With Metastatic Melanoma
- Lead sponsor
- Novartis
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 23, 2021
- Completion date
- April 13, 2023
- Enrollment
- 1,795 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic melanoma